US$ 21.03
semaglutide oral suspension Drops Oral Semaglutide for Weight Loss
Description
Most common side effect, typically resolves within hours

Koeth et al

Clinical trials show that patients who begin at 0.25 mg and titrate upward every 14 weeks report 4050% fewer moderate-to-severe nausea episodes compared to those jumping to higher doses immediately
Retatrutide is an investigational triple agonist (GLP-1, GIP, glucagon) peptide injectable not yet licensed by the MHRA or EMA

You can ask your doctor, I read online about splitting the dose to help with side effects
